SBC / revenue moved 307 bp higher
SBC / revenue changed +307 basis points from the comparable as-filed period.
0.91%→3.98%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ACFN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 578 bp higher
Working capital / assets changed +578 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
21.77%→27.55%4 prior comparisons
Receivables / revenue moved 1780 bp lower
Receivables / revenue changed -1780 basis points from the comparable as-filed period.
60.71%→42.91%2 prior comparisons
Current ratio increased 27.4%
Current ratio changed +27.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.67→2.124 prior comparisons
Research & development decreased 9.8%
Research & development changed -9.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$265,000→$239,0003 prior comparisons
Inventory increased 18.3%
Inventory changed +18.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$953,000→$1.1M4 prior comparisons
Total assets increased 6.8%
Total assets changed +6.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$12.5M→$13.4M4 prior comparisons
R&D / revenue moved 208 bp higher
R&D / revenue changed +208 basis points from the comparable as-filed period.
7.52%→9.60%3 prior comparisons
Shares outstanding increased 0.3%
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
2,501,440→2,509,6188 prior comparisons
Current assets increased 2.2%
Current assets changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6.8M→$7.0M4 prior comparisons
Selling, general & administrative increased 0.6%
Selling, general & administrative changed +0.6% from the comparable as-filed period.
$1.4M→$1.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.